| Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease D Morgan, DM Diamond, PE Gottschall, KE Ugen, C Dickey, J Hardy, ... Nature 408 (6815), 982-985, 2000 | 2163 | 2000 |
| Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models MV Lourenco, RL Frozza, GB de Freitas, H Zhang, GC Kincheski, ... Nature medicine 25 (1), 165-175, 2019 | 816 | 2019 |
| Vascular contributions to cognitive impairment and dementia including Alzheimer's disease HM Snyder, RA Corriveau, S Craft, JE Faber, SM Greenberg, D Knopman, ... Alzheimer's & Dementia 11 (6), 710-717, 2015 | 673 | 2015 |
| Assessing activation states in microglia CA Colton, DM Wilcock CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2010 | 523 | 2010 |
| Passive immunotherapy against Aβ in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and … DM Wilcock, A Rojiani, A Rosenthal, S Subbarao, MJ Freeman, ... Journal of neuroinflammation 1, 1-11, 2004 | 491 | 2004 |
| International society to advance Alzheimer’s research and treatment, Alzheimer’s association GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Perspectives on ethnic and racial disparities in Alzheimer’s disease and …, 2019 | 447 | 2019 |
| White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): knowledge gaps and opportunities J Alber, S Alladi, HJ Bae, DA Barton, LA Beckett, JM Bell, SE Berman, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 5 …, 2019 | 406 | 2019 |
| Intracranially administered anti-Αβ antibodies reduce β-amyloid deposition by mechanisms both independent of and associated with microglial activation DM Wilcock, G DiCarlo, D Henderson, J Jackson, K Clarke, KE Ugen, ... Journal of Neuroscience 23 (9), 3745-3751, 2003 | 388 | 2003 |
| Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition DM Wilcock, A Rojiani, A Rosenthal, G Levkowitz, S Subbarao, J Alamed, ... Journal of Neuroscience 24 (27), 6144-6151, 2004 | 381 | 2004 |
| Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: update and areas of immediate need GM Babulal, YT Quiroz, BC Albensi, E Arenaza-Urquijo, AJ Astell, ... Alzheimer's & Dementia 15 (2), 292-312, 2019 | 380 | 2019 |
| Two-day radial-arm water maze learning and memory task; robust resolution of amyloid-related memory deficits in transgenic mice J Alamed, DM Wilcock, DM Diamond, MN Gordon, D Morgan Nature protocols 1 (4), 1671-1679, 2006 | 314 | 2006 |
| Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+ APP mouse MN Gordon, LA Holcomb, PT Jantzen, G DiCarlo, D Wilcock, KW Boyett, ... Experimental neurology 173 (2), 183-195, 2002 | 306 | 2002 |
| Intrahippocampal LPS injections reduce Aβ load in APP+ PS1 transgenic mice G DiCarlo, D Wilcock, D Henderson, M Gordon, D Morgan Neurobiology of aging 22 (6), 1007-1012, 2001 | 298 | 2001 |
| Down’s syndrome, neuroinflammation, and Alzheimer neuropathogenesis DM Wilcock, WST Griffin Journal of neuroinflammation 10, 1-10, 2013 | 289 | 2013 |
| Vascular amyloid alters astrocytic water and potassium channels in mouse models and humans with Alzheimer's disease DM Wilcock, MP Vitek, CA Colton Neuroscience 159 (3), 1055-1069, 2009 | 266 | 2009 |
| Microglial activation facilitates Aβ plaque removal following intracranial anti-Aβ antibody administration DM Wilcock, SK Munireddy, A Rosenthal, KE Ugen, MN Gordon, ... Neurobiology of disease 15 (1), 11-20, 2004 | 262 | 2004 |
| Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics D Morgan, MN Gordon, J Tan, D Wilcock, AM Rojiani Journal of Neuropathology & Experimental Neurology 64 (9), 743-753, 2005 | 242 | 2005 |
| Neuroinflammatory phenotype in early Alzheimer's disease TL Sudduth, FA Schmitt, PT Nelson, DM Wilcock Neurobiology of aging 34 (4), 1051-1059, 2013 | 236 | 2013 |
| Neuroinflammation in Alzheimer’s disease; A source of heterogeneity and target for personalized therapy CH Latta, HM Brothers, DM Wilcock Neuroscience 302, 103-111, 2015 | 222 | 2015 |
| The roles of inflammation and immune mechanisms in Alzheimer's disease LJ Van Eldik, MC Carrillo, PE Cole, D Feuerbach, BD Greenberg, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 2 (2 …, 2016 | 217 | 2016 |
